TCON — TRACON Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00- $0.15m
- -$6.12m
- $12.05m
- 41
- 93
- 14
- 47
Annual cashflow statement for TRACON Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -22.7 | -16.8 | -28.7 | -29.1 | -3.59 |
| Depreciation | |||||
| Non-Cash Items | 1.88 | 1.17 | 1.54 | 3.12 | 9.4 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -2.88 | -1.45 | 4.54 | -0.239 | -2.15 |
| Change in Prepaid Expenses | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -23.6 | -17 | -22.6 | -26.2 | 3.68 |
| Capital Expenditures | 0 | -0.005 | -0.048 | -0.017 | 0 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 14 | -4 | 4 | 0 | 0 |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | 14 | -4 | 3.95 | -0.017 | 0 |
| Financing Cash Flow Items | -0.02 | — | — | 3.43 | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.906 | 36.8 | 10.6 | 19.7 | -12.5 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -8.72 | 15.7 | -8.06 | -6.57 | -8.86 |